Human immunodeficiency virus type-2-A milder, kinder virus: An update

Indian Journal of Medical Microbiology

Volumn 30, Issue 1, 2012, Pages 6-15

  Kannangai, R ^a   David, S ^b   Sridharan, G ^a  

^a Sri Narayani Hospital and Research Centre   (India)

^b CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

Drug resistance; HIV; Human immunodeficiency virus type 2; mutations

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; IMMUNE DEFICIENCY; REVIEW; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS REPLICATION; VIRUS TRANSMISSION;

EID: 84857811092     PISSN: 02550857     EISSN: 19983646     Source Type: Journal    
DOI: 10.4103/0255-0857.93014     Document Type: Review

References (69)

1. Gallo RC, Sarin PS, Gelmann EP, Robert-Guroff M, Richardson E, Kalyanaraman VS, et al. Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS). Science 1983;220:865-7.
2. Sharp PM, Bailes E, Gao F, Beer BE, Hirsch VM, Hahn BH. Origins and evolution of AIDS viruses: Estimating the timescale. Biochem Soc Trans 2000;28:275-82.
3. Hahn BH, Shaw GM, De Cock KM, Sharp PM. AIDS as a zoonosis: Scientific and public health implications. Science 2000;287:607-14.
4. Lemey P, Pybus OG, Wang B, Saksena, NK, Salemi M, Vandamme AM. Tracing the origin and history of the HIV-2 epidemic. Proc Natl Acad Sci USA, 2003;100:6588-92.
5. Poulsen AG, Aaby P, Gottschau A, Kvinesdal BB, Dias F, Molbak K, et al. HIV-2 infection in Bissau, West Africa, 1987-1989: Incidence, prevalences, and routes of transmission. J Acquir Immune Defic Syndr 1993;6:941-8.
6. Smallman-Raynor M, Cliff A. The spread of human immunodeficiency virus type 2 into Europe: A geographical analysis. Int J Epidemiol 1991;20:480-9.
7. Rubsamen-Waigmann H, Briesen HV, Maniar JK, Rao PK, Scholz, C, Pfutzner A. Spread of HIV-2 in India. Lancet 1991;337:550-1.
8. Babu PG, Saraswathi NK, Devapriya F, John T J. The detection of HIV-2 infection in southern India. Indian J Med Res 1993;97:49-52.
9. Kanki PJ, M'Boup S, Ricard D, Barin F, Denis F, Boye C, et al. Human T-lymphotropic virus type 4 and the human immunodeficiency virus in West Africa. Science 1987;236:827-31.
10. Norrgren H, Cardoso AN, da Silva ZJ, Andersson S, Dias F, Biberfeld G, et al. Increased prevalence of HIV-2 infection in hospitalized patients with severe bacterial diseases in Guinea-Bissau. Scand J Infect Dis 1997;29:453-9.
11. Kannangai R, Ramalingam S, Vijayakumar TS, Prabu K, Jesudason MV, Sridharan G. HIV-2 sub-epidemic not gathering speed: Experience from a tertiary care center in South India. J Acquir Immune Defic Syndr 2003;32:573-5.
12. Kulkarni S, Thakar M, Rodrigues J, Banerjee K. HIV-2 antibodies in serum samples from Maharashtra state. Indian J Med Res 1992;95:213-5.
13. Barin F, Cazein F, Lot F, Pillonel J, Brunet S, Thierry D, et al. Prevalence of HIV-2 and HIV-1 group O infections among new HIV diagnoses in France: 2003-2006. AIDS 2007;21:2351-3.
14. Roberts JD, Bebenek K, Kunkel TA. The accuracy of reverse transcriptase from HIV-1. Science 1988;242:1171-3.
15. Bjorling E, Broliden K, Bernardi D, Utter G, Thorstensson R, Chiodi F, et al. Hyperimmune antisera against synthetic peptides representing the glycoprotein of human immunodeficiency virus type 2 can mediate neutralization and antibody-dependent cytotoxic activity. Proc Natl Acad Sci U S A 1991;88:6082-6.
16. Sankale JL, de la Tour RS, Renjifo B, Siby T, Mboup S, Marlink RG, et al. Intrapatient variability of the human immunodeficiency virus type 2 envelope V3 loop. AIDS Res Hum Retroviruses 1995;11:617-23.
17. Chen Z, Luckay A, Sodora DL, Telfer P, Reed P, Gettie A, et al. Human immunodeficiency virus type 2 (HIV-2) seroprevalence and characterization of a distinct HIV-2 genetic subtype from the natural range of simian immunodeficiency virus-infected sooty mangabeys. J Virol 1997;71:3953-60.
18. Yamaguchi J, Devare SG, Brennan CA. Identification of a new HIV-2 subtype based on phylogenetic analysis of full-length genomic sequence. AIDS Res Hum Retroviruses 2000;16: 925-30.
19. Grez M, Dietrich U, Balfe P, von Briesen H, Maniar JK, Mahambre G, et al. Genetic analysis of human immunodeficiency virus type 1 and 2 (HIV-1 and HIV-2) mixed infections in India reveals a recent spread of HIV-1 and HIV-2 from a single ancestor for each of these viruses. J Virol 1994;68:2161-8.
20. Kannangai R, Shaji RV, Ramalingam S, Jesudason MV, Abraham OC, George R, et al. HIV-2 subtype circulating in India (south). J Acquir Immune Defic Syndr 2003;33:219-22.
21. Bhanja P, Mandal DK, Jana S, Bhattacharya SK, Chakrabarti S. Detection and characterization of HIV type 2 in Calcutta, India. AIDS Res Hum Retroviruses 2004;20:101-4.
22. Santhosh CV, Tamhane MC, Mukhopadhyaya R, Mukhopadhyaya R. Full-length genome characterization of an HIV type 2 isolate from India. AIDS Res Hum Retroviruses 2008;24:1315-7.
23. Jadhav S, Tripathy S, Kulkarni S, Agnihotri K, Risbud A, Paranjape R. Molecular phylogenetics of nearly full-length HIV type 2 envelope gene sequences from West India. AIDS Res Hum Retroviruses 2009;25:115-21.
24. Gurjar SR, Mangaiarkarasi A, Ravi V, Ranga U, Desai A. Molecular characterization of a full-length genome of a HIV-2 isolate from India. J Acquir Immune Defic Syndr 2009;52:329-35.
25. Kanki PJ, Travers KU, Hsieh CC, Marlink RG, Gueye NA, Siby T, et al. Slower heterosexual spread of HIV-2 than HIV-1. Lancet 1994;343:943-6.
26. Norrgren H, Andersson S, Biague AJ, da Silva ZJ, Dias F, Naucler A, et al. Trends and interaction of HIV-1 and HIV-2 in Guinea-Bissau, west Africa: No protection of HIV-2 against HIV-1 infection. AIDS 1999;13:701-7.
27. Del Mistro A, Chotard J, Hall AJ, Whittle H, De Rossi A, Chieco-Bianchi L. HIV-1 and HIV-2 seroprevalence rates in mother-child pairs living in The Gambia (West Africa). J Acquir Immune Defic Syndr 1992;5:19-24.
28. Poulsen AG, Kvinesdal BB, Aaby P, Lisse IM, Gottschau A, Molbak K, et al. Lack of evidence of vertical transmission of human immunodeficiency virus type 2 in a sample of the general population in Bissau. J Acquir Immune Defic Syndr 1992;5:25-30.
29. Adjorlolo-Johnson G, De Cock KM, Ekpini E, Vetter KM, Sibailly T, Brattegaard K, et al. Prospective comparison of mother-to-child transmission of HIV-1 and HIV-2 in Abidjan, Ivory Coast. JAMA 1994;272:462-6.
30. Simmons G, Reeves JD, Hibbitts S, Stine JT, Gray PW, Proudfoot AE, et al. Co-receptor use by HIV and inhibition of HIV infection by chemokine receptor ligands. Immunol Rev 2000;177:112-26.
31. McKnight A, Dittmar MT, Moniz-Periera J, Ariyoshi K, Reeves JD, Hibbitts S, et al. A broad range of chemokine receptors are used by primary isolates of human immunodeficiency virus type 2 as coreceptors with CD4. J Virol 1998;72:4065-71.
32. Chen YH, Xiao Y, Wu W, Wang Q, Luo G, Dierich MP. HIV-2 transmembrane protein gp36 binds to the putative cellular receptor proteins P45 and P62. Immunobiology 2000;201:317-22.
33. Kulkarni S, Tripathy S, Agnihotri K, Jatkar N, Jadhav S, Umakanth W, et al. Indian primary HIV-2 isolates and relationship between V3 genotype, biological phenotype and coreceptor usage. Virology 2005;337:68-75
34. Fauci AS. Immunopathogenesis of HIV infection. J Acquir Immune Defic Syndr 1993;6:655-62.
35. Marlink R, Kanki P, Thior I, Travers K, Eisen G, Siby T, et al. Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science 1994;265:1587-90.
36. Chollet-Martin S, Simon F, Matheron S, Joseph CA, Elbim C, Gougerot-Pocidalo MA. Comparison of plasma cytokine levels in African patients with HIV-1 and HIV-2 infection. AIDS 1994;8:879-84.
37. Belshan M, Mahnke LA, Ratner L. Conserved amino acids of the human immunodeficiency virus type 2 Vpx nuclear localization signal are critical for nuclear targeting of the viral preintegration complex in non-dividing cells. Virology 2006;346:118-26.
38. Vanham G, van Tendeloo V, Willems B, Penne L, Kestens L, Beirnaert E, et al. The HIV-2 genotype and the HIV-1 syncytium-inducing phenotype are associated with a lower virus replication in dendritic cells. J Med Virol 2000;60; 300-12.
39. Popper SJ, Sarr AD, Travers KU, Gueye-Ndiaye A, Mboup S, Essex ME, et al. Lower human immunodeficiency virus (HIV) type 2 viral load reflects the difference in pathogenicity of HIV-1 and HIV-2. J Infect Dis 1999;180:1116-21.
40. Ariyoshi K, Jaffar S, Alabi AS, Berry N, van der Loeff MS, Sabally S, et al. Plasma RNA viral load predicts the rate of CD4 T cell decline and death in HIV-2-infected patients in West Africa. Aids 2000;14:339-44.
41. O'Brien TR, Blattner WA, Waters D, Eyster E, Hilgartner MW, Cohen AR, et al. Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study. JAMA 1996;276:105-10.
42. Simon F, Matheron S, Tamalet C, Loussert-Ajaka I, Bartczak S, Pepin JM, et al. Cellular and plasma viral load in patients infected with HIV-2. AIDS 1993;7:1411-7.
43. Jaffar S, Wilkins A, Ngom PT, Sabally S, Corrah T, Bangali JE, et al. Rate of decline of percentage CD4+ cells is faster in HIV-1 than in HIV-2 infection. J Acquir Immune Defic Syndr Hum Retrovirol 1997;16:327-32.
44. Albert J, Naucler A, Bottiger B, Broliden PA, Albino P, Ouattara SA, et al. Replicative capacity of HIV-2, like HIV-1, correlates with severity of immunodeficiency. AIDS 1990;4:291-5.
45. Schramm B, Penn ML, Palacios EH, Grant RM, Kirchhoff F, Goldsmith MA. Cytopathicity of human immunodeficiency virus type 2 (HIV-2) in human lymphoid tissue is coreceptor dependent and comparable to that of HIV-1. J Virol 2000;74:9594-600.
46. Thomas ER, Shotton C, Weiss RA, Clapham PR, McKnight A. CD4-dependent and CD4-independent HIV-2: Consequences for neutralization. AIDS 2003;17:291-300.
47. Tamalet C, Simon F, Dhiver C, Matheron S, de Micco P, Gastao JA. et al. Autologous neutralizing antibodies and viral load in HIV-2-infected individuals. AIDS 1995;9:90-1.
48. Cavaleiro R, Sousa AE, Loureiro A, Victorino RM. Marked immunosuppressive effects of the HIV-2 envelope protein in spite of the lower HIV-2 pathogenicity. AIDS 2000;14: 2679-86.
49. Sekigawa I, Kaneko H, Neoh LP, Takeda-Hirokawa N, Akimoto H, Hishikawa T, et al. Differences of HIV envelope protein between HIV-1 and HIV-2: Possible relation to the lower virulence of HIV-2. Viral Immunol 1998;11:1-8.
50. Lisse IM, Poulsen AG, Aaby P, Normark M, Kvinesdal B, Dias F, et al. Immunodeficiency in HIV-2 infection: A community study from Guinea-Bissau. AIDS 1990;4:1263-6.
51. Ariyoshi K, Cham F, Berry N, Jaffar S, Sabally S, Corrah T, et al. HIV-2-specific cytotoxic T-lymphocyte activity is inversely related to proviral load. AIDS 1995;9:555-9.
52. Cavaleiro R, Baptista AP, Foxall RB, Victorino RM, Sousa AE. Dendritic cell differentiation and maturation in the presence of HIV type 2 envelope. AIDS Res Hum Retroviruses 2009;25:425-31.
53. Matsuyama T, Kobayashi N, Yamamoto N. Cytokines and HIV infection: Is AIDS a tumor necrosis factor disease? AIDS 1991;5:1405-17.
54. Sousa AE, Chaves AF, Loureiro A, Victorino RM. Comparison of the frequency of interleukin (IL)-2-, interferongamma-, and IL-4-producing T cells in 2 diseases, human immunodeficiency virus types 1 and 2, with distinct clinical outcomes. J Infect Dis 2001;184:552-9.
55. Ramalingam S, Kannangai R, Vijayakumar TS, Mathai D, Abraham OC, Subramanian S, et al. Subtype and cytokine profiles of HIV infected individuals from south India. Indian J Med Res 2005;121:226-34.
56. De Cock KM, Odehouri K, Colebunders RL, Adjorlolo G, Lafontaine MF, Porter A, et al. A comparison of HIV-1 and HIV-2 infections in hospitalized patients in Abidjan, Cote d'Ivoire. AIDS 1990;4:443-8.
57. Nkengasong JN, Maurice C, Koblavi S, Kalou M, Bile C, Yavo D, et al. Field evaluation of a combination of monospecific enzyme-linked immunosorbent assays for typespecific diagnosis of human immunodeficiency virus type 1 (HIV-1) and HIV-2 infections in HIV-seropositive persons in Abidjan, Ivory Coast. J Clin Microbiol 1998;36:123-7.
58. Kannangai R, Ramalingam S, Prakash KJ, Abraham OC, George R, Castillo RC, et al. A peptide enzyme linked immunosorbent assay (ELISA) for the detection of human immunodeficiency virus type-2 (HIV-2) antibodies: An evaluation on polymerase chain reaction (PCR) confirmed samples. J Clin Virol 2001;22:41-6.
59. Ampofo WK, Koyanagi Y, Brandful J, Ishikawa K, Yamamoto N. Seroreactivity clarification and viral load quantitation in HIV-1 and HIV-2 infections in Ghana. J Med Dent Sci 1999;46:53-62.
60. Kannangai R, Ramalingam S, Prabu K, Jesudason MV, Sridharan G. Evaluation of two rapid HIV screening tests for the detection of HIV-2 antibody. J Acquir Immune Defic Syndr 2002;29:320-1.
61. Damond F, Loussert-Ajaka I, Apetrei C, Descamps D, Souquiere S, Lepretre A, et al. Highly sensitive method for amplification of human immunodeficiency virus type 2 DNA. J Clin Microbiol 1998;36:809-11.
62. Peeters M, Gershy-Damet GM, Fransen K, Koffi K, Coulibaly M, Delaporte E, et al. Virological and polymerase chain reaction studies of HIV-1/HIV-2 dual infection in Cote d'Ivoire. Lancet 1992;340:339-40.
63. Kulkarni SS, Tripathy S, Paranjape RS, Mani NS, Joshi DR, Patil U, et al. Isolation and preliminary characterization of two HIV-2 strains from Pune, India. Indian J Med Res 1999;109:123-30.
64. Damond F, Gueudin M, Pueyo S, Farfara I, Robertson DL, Descamps D, et al. Plasma RNA viral load in human immunodeficiency virus type 2 subtype A and subtype B infections. J Clin Microbiol 2002;40:3654-9.
65. Rodes B, Holguin A, Soriano V, Dourana M, Mansinho K, Antunes F, et al. Emergence of drug resistance mutations in human immunodeficiency virus type 2-infected subjects undergoing antiretroviral therapy. J Clin Microbiol 2000;38:1370-4.
66. Smith RA, Anderson DJ, Pyrak CL, Preston BD, Gottlieb GS. Antiretroviral drug resistance in HIV-2: Three amino acid changes are sufficient for classwide nucleoside analogue resistance. J Infect Dis 2009;199:1323-6.
67. Loussert-Ajaka I, Simon F, Farfara I, Collin G, Saimot AG, Brun-Vezinet F. Virological diagnosis of mixed HIV-1/HIV-2 infection. J Acquir Immune Defic Syndr 1993;6:1284-5.
68. Travers K, Mboup S, Marlink R, Gueye-Nidaye A, Siby T, Thior I, et al. Natural protection against HIV-1 infection provided by HIV-2. Science 1995;268:1612-5.
69. Greenberg AE. Possible protective effect of HIV-2 against incident HIV-1 infection: Review of available epidemiological and in vitro data. AIDS 2001;15:2319-21.